Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors

This multicenter cohort study indicates that using predictors such as baseline PDAI score, anti-DSG1 antibodies, and/or anti-DSG3 antibodies to initiate preemptive treatment with additional rituximab may reduce the rate of short-term relapse.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2025-02-05
DOI
https://doi.org/10.1001/jamadermatol.2024.6130
Citations
5
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
7.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors

Sami Hamwi, M. Viguier, Alexis Lefebvre, Emmanuelle Tancrède‐Bohin et al.
5 citations
JAMA Dermatology
Autoimmune Bullous Skin Diseases
7.36
article

Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors

Sami Hamwi, M. Viguier, Alexis Lefebvre, Emmanuelle Tancrède‐Bohin, N. Cordel, C. Lepelletier, F. Caux, A. Brue, G. Jeudy, S. Duvert‐Lehembre, S. Debarbieux, P. Joly, M. Fenot, V. Hébert, M. Alexandre, Anne Pham‐Ledard, Billal Tedbirt, M. D’Incan, Gaelle Quereux, V. Seta, Saskia Ingen-Housz-Oro
article en
5 citations

Abstract

This multicenter cohort study indicates that using predictors such as baseline PDAI score, anti-DSG1 antibodies, and/or anti-DSG3 antibodies to initiate preemptive treatment with additional rituximab may reduce the rate of short-term relapse.

JAMA DermatologyVol. 161(4)
Inserm (FR), Université Paris-Est Créteil (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Université Sorbonne Paris Nord (FR), Assistance Publique – Hôpitaux de Paris (FR), Normandie Université (FR), Roche (France) (FR), Centre Hospitalier Universitaire d'Angers (FR), Hôpital Lyon Sud (FR), CHU Dijon Bourgogne (FR), Hôpital Robert-Debré (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Hôpitaux Universitaires Henri-Mondor (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Départemental Vendée (FR), Centre Hospitalier Universitaire de Rouen (FR), BoRdeaux Institute of onCology (FR), Université de Rouen Normandie (FR), Université de Reims Champagne-Ardenne (FR), Nantes Université (FR)
Good health and well-being
Openalex Percentile: Top 3%
Autoimmune Bullous Skin Diseases
7.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.